Tetra Bio-Pharma Inc.
TBPMQ
$0.00
$0.000.00%
OTC PK
| 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -17.55% | -23.75% | -53.96% | -109.96% | -82.47% |
| Total Depreciation and Amortization | 17.77% | 161.92% | 195.91% | 260.48% | 66.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 567.28% | 330.45% | 475.55% | 529.25% | 110.68% |
| Change in Net Operating Assets | 382.62% | -136.27% | -213.78% | -132.78% | -239.07% |
| Cash from Operations | 73.37% | 42.02% | -24.55% | -38.33% | -101.19% |
| Capital Expenditure | 96.96% | 71.93% | 58.58% | -48.61% | 11.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 76.49% | 79.09% | 50.22% | 40.40% | -127.42% |
| Cash from Investing | 78.85% | 78.35% | 51.19% | 34.18% | -92.88% |
| Total Debt Issued | -100.00% | -100.00% | -28.57% | -- | -- |
| Total Debt Repaid | 27.43% | 46.35% | -128.72% | -- | -- |
| Issuance of Common Stock | -91.64% | -91.55% | 136.33% | 16.30% | 16.30% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 85.07% | 85.07% | -115.83% | 24.27% | -75.15% |
| Cash from Financing | -97.42% | -96.11% | 139.26% | 37.68% | 26.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -123.52% | -2,488.25% | 126.08% | 914.01% | -151.64% |